Ardelyx, Inc. (ARDX) income statement
ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3060% below fair value
$2.99−0.07 (-2.29%)
Close on Nov 20, 2026Market cap $745.07MP/E –Yield –
Ardelyx, Inc. financial ratios
See a number that looks wrong?